PTK2 and pancreatic neoplasm: In a related study we investigated the effects of the focal adhesion kinase (FAK) inhibitor (PF-562,271) on pancreatic cancer and stromal cell migration in vitro and assessed its effects on tumor growth and metastasis in an orthotopic murine model [4].